Page last updated: 2024-08-25

rosiglitazone and Pterygium

rosiglitazone has been researched along with Pterygium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kim, SW; Nuwormegbe, SA; Sohn, JH	1

Other Studies

1 other study(ies) available for rosiglitazone and Pterygium

Article	Year
A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway. Investigative ophthalmology & visual science, 2017, 10-01, Volume: 58, Issue:12 Topics: Actins; Apoptosis; Blotting, Western; Cells, Cultured; Extracellular Matrix Proteins; Fibrosis; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Humans; Hypoglycemic Agents; Myofibroblasts; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Pterygium; Real-Time Polymerase Chain Reaction; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta1	2017

Article

Year

A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.

Investigative ophthalmology & visual science, 2017, 10-01, Volume: 58, Issue:12

Topics: Actins; Apoptosis; Blotting, Western; Cells, Cultured; Extracellular Matrix Proteins; Fibrosis; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Humans; Hypoglycemic Agents; Myofibroblasts; p38 Mitogen-Activated Protein Kinases; PPAR gamma; Pterygium; Real-Time Polymerase Chain Reaction; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta1

2017